, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of
from last year or 208.95 Baht. This is mainly due to the fact that in 2017, GWM’s revenue streams are mostly from medical product distribution as the hemodialysis solution production plant was still
delivered income thus also resulting from company has concentrate on cost management Cost of distribution as amount of 6.42 Million Bath as 3.66 Million Baht decreased or 36.29 percent when compared to same
, Line Official Account: @fnoutlet as well as other marketplaces e.g. Shopee, Lazada etc. Industry Overview Thai economy in 3Q19 was slowdown. Impacts from slowdown in trading partners’ economy continually
and irrigation agencies that had already been accelerated. State-owned enterprises' capital expenditure contracted in line with disbursements in energy and transportation investment projects. However
prepare for an increased level of production and the Company’s growth from 2018 onwards; 3) cost from trial runs and start-up of a new production line for some products, driving higher yield loss and cost
%) 5.31 0.05% 4.29 0.04% (1.02) (19.20%) Total revenues 3,590.56 100.00% 3,587.58 100.00% (2.98) (0.08%) 11,264.47 100.00% 10,340.77 100.00% (923.69) (8.20%) Distribution costs 184.53 5.14% 159.17 4.44
Company’s major export counties. Export CMG sales decreased by c.50% YoY, since there was some customer ending the distribution contract with some retailer which resulted in reduced sales volume since Q4
the performance in each business line were explained as follows: JMART Group MD&A: FS2019 IR63/002 : 26 February 2020 JMART Group MD&A: FS2019 “In 2019, which was considered the highest net profit in 30
354,032 38,198 44.12 Selling and distribution expenses 104,588 106,427 (1,839) (1.7) 95,785 93,788 1,997 2.1 Administrative expenses 180,753 174,720 6,033 3.5 131,619 123,826 7,793 6.3 Loss on impairment of